Smiths Falls-based Canopy Growth will study the effects on cannabinoids on patients facing complications from concussions thanks to a new partnership with the NHL Alumni Association and Neeka Health Canada.
If successful, the partners hope the research could unlock new avenues to use cannabinoids in post-concussion treatment for athletes and everyday patients.
The local pot producer announced over the weekend it will work with its partners to determine how effective cannabis can be in addressing common post-concussion complications, such as depression, dementia or chronic traumatic encephalopathy (CTE).
OBJ360 (Sponsored)
How the uOttawa faculty of engineering instills an ‘entrepreneurial mindset’ in students
A decade ago, Terrafixing chief operating officer Vida Gabriel was a chemistry-loving student in high school with little to no interest in business or entrepreneurship. “I didn’t like the sales
The value of an Algonquin College degree: Experiential learning, taught by industry experts
Zaahra Mehsen was three years into a biology degree at a local university when she realized she wanted to take a different path. “I realized that it’s not my thing,”
The research will look to improve cognitive functions for the estimated 1.6 million to 3.8 million athletes that suffer concussions annually, 10 to 15 per cent of whom go on to develop symptoms of mental degradation. About 100 former NHL players will participate in the study.
Trials will begin this summer and are expected to last one year.
